NCT01513603View on ClinicalTrials.gov

Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia

PHASE2UnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Acute Lymphoblastic LeukemiaLymphoblastic LymphomaBurkitts Leukemia/LymphomaChronic Myelogenous Leukemia
Interventions
DRUG

CLAG-M

IV times 5 days

DRUG

CLAG-M

Chemotherapy

Trial Locations (1)

10595

RECRUITING

Westchester Medical Center/New York Medical College, Valhalla

Sponsors
All Listed Sponsors
lead

New York Medical College

OTHER

NCT01513603 - Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter